Evidence map›Paper›PMID 28791703›Full record

ReviewJournal of neurochemistry2017

The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation.

Ian McLaughlin, John A Dani, Mariella De Biasi

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Predictive biomarkers of placebo response in patients with cancer: an exploratory analysis of the ABCD randomized clinical trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  3. Asymmetrical modulation of fear expression via GABAProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  17. Article
  18. On analogies in vertebrate and insect visual systems.Nature reviews. Neuroscience · 2025
    Review
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ian McLaughlinDepartment of Psychiatry, Mahoney Institute for Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John A DaniDepartment of Neuroscience, Mahoney Institute for Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mariella De BiasiDepartment of Psychiatry, Mahoney Institute for Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
University of Pennsylvania · USNeurosciences Institute · US

Funding

UPENN TCORS: Tobacco Product Messaging in a Complex Communication EnvironmentP50CA179546 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HORNIK, ROBERT C. · 2013 to 2017
$18.7M
STRUCTURE/FUNCTION OF EXCITATORY SYNAPTIC CHANNELSR01NS021229 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 1987 to 2021
$5.3M
T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
CELLULAR MECHANISMS OF NICOTINE ADDICTIONR01DA009411 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 1997 to 2018
$5.0M
Stress, Anxiety, and Nicotine WithdrawalR01DA017173 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI DE BIASI, MARIELLA · 2003 to 2010
$2.2M
CHOLINERGIC INFLUENCES NEURONAL CIRCUIT EXCITABILITYR37NS021229 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DANI, JOHN A. · 2000 to 2006
$2.1M
Genetic Influences Over Nicotine WithdrawalR21DA029157 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI DE BIASI, MARIELLA · 2010 to 2011
$420k
NCI NIH HHS P50 CA179546NIDA NIH HHS R01 DA009411NIDA NIH HHS R01 DA017173NIDA NIH HHS R21 DA029157NIDA NIH HHS T32 DA028874NINDS NIH HHS R01 NS021229NINDS NIH HHS R37 NS021229
6 · The paper itself

Abstract

Abstinence from chronic use of addictive drugs triggers an aversive withdrawal syndrome that compels relapse and deters abstinence. Many features of this syndrome are common across multiple drugs, involving both affective and physical symptoms. Some of the network signaling underlying withdrawal symptoms overlaps with activity that is associated with aversive mood states, including anxiety and depression. Given these shared features, it is not surprising that a particular circuit, the dorsal diencephalic conduction system, and the medial habenula (MHb) and interpeduncular nucleus (IPN), in particular, have been identified as critical to the emergence of aversive states that arise both as a result and, independently, of drug addiction. As the features of this circuit continue to be characterized, the MHb-IPN axis is emerging as a viable target for therapeutics to aid in the treatment of addiction to multiple drugs of abuse as well as mood-associated disorders. This is an article for the special issue XVth International Symposium on Cholinergic Mechanisms.

Indexed as

AffectAnimalsAnxietyBehavior, AddictiveHumansInterpeduncular NucleusNicotinic AgonistsSubstance Withdrawal SyndromeNicotinic Agonistsalcoholepithalamusinterpeduncular nucleusmoodstresswithdrawal

Identifiers

PMID28791703
PMCPMC6740332
OpenAlexW2743911202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.